Copenhagen, 2014-04-04 09:59 CEST (GLOBE NEWSWIRE) -- Copenhagen, 4 April 2014 - Zealand Pharma (“Zealand”) (NASDAQ OMX Copenhagen: ZEAL) announces that a total of 100,000 new warrants have been issued to Torsten Hoffmann, Executive Vice President and Chief Scientific Officer. The warrants have been issued under an existing warrant incentive scheme, established by the company’s Board of Directors under the authority provided by Section 8.1 of the Articles of Association as announced in Company Announcement no. 5/2014 of 1 April 2014.
Help employers find you! Check out all the jobs and post your resume.
